| Home | E-Submission | Sitemap | Contact Us |  
top_img
J Korean Cancer Assoc > Volume 7(1); 1972 > Article
Journal of the Korean Cancer Association 1972;7(1): 23-49.
「 리보누크리에스 」 의 인체악성종양에 있어서의 치료효과
윤탁구, 김용규, 김겸수, 박흥길, 박수성, 고창순, 김진용, 박기복
CLINICAL STUDIES ON THE CARCINOLYTIC ACTION OF BOVINE PANCREATIC RIBONUCLEASE
Taik Koo Yun, Yong Kyu Kim, Byung Soo Kim, Heung Kil Park, Soo Sung Park, Chang Soo Koh, Jin Yong Kim, Ki Bok Park
ABSTRACT
A few studies on the anti-cancer effects of ribonuclease have been carried out in experimental tumors with a limited success. This study is designed to demonstrate the carcinolytic action of bovine pancreatic ribonuclease in the human subjects. Twenty-three cases with various types of objectively measurable neoplastic diseases such as hemangioendothelioma, squamous cell carcinoma, fibrosarcoma, lymphatic metastastasis of hepatoma, carcinomatous peritonitis, carcinomatous pleurisy, liosarcoma, synovial sarcoma, malignant lymphoma, malignant giant cell tumor, leukemia bronchogenic carcinoma and stomach cancer were selected for the current investigation. Bovine pancreatic ribonuclease was administered by topical, intracavitary, intramuscular and intravenous routes with dose schedule of 1.0 to 3.0 mg per kg of body weight per day for five to thirty-five days. In the group in which the enzyme was topically administered, marked regression or disappearance and carcinolysis of tumors were observed in cases of fibrosarcoma, liposarcoma, synovial sarcoma and in some cases of squamous cell carcinoma. The enzyme itself appeared to have no myelodepressive action. However, allergic shock occurred in two cases after the repeated course of topical administration. It appears from these observations that ribonuclease might be of use as an anticancer agent especially in fibrosarcoma, liposarcoma and synovial sarcoma which are known to be relatively resistant to radiotherapy.
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
2,260
View
15
Download
Related article
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI